Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution

Molecular Oncology

Volumn 6, Issue 5, 2012, Pages 553-564

  Cerveira, Nuno ^a   Lisboa, Susana ^a   Correia, Cecília ^a   Bizarro, Susana ^a   Santos, Joana ^a   Torres, Lurdes ^a   Vieira, Joana ^a   Barros Silva, João D ^a   Pereira, Dulcineia ^a   Moreira, Cláudia ^a   Meyer, Claus ^b   Oliva, Tereza ^a   Moreira, Ilídia ^a   Martins, Ângelo ^a   Viterbo, Luísa ^a   Costa, Vítor ^a   Marschalek, Rolf ^b   Pinto, Armando ^a   Mariz, José M ^a   Teixeira, Manuel R ^a,c  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Acute leukemia; Gene fusions; MLL gene

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN; SEPTIN;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER PROGNOSIS; CHILD; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE INSERTION; GENE TRANSLOCATION; HUMAN; INFANT; MALE; MOLECULAR GENETICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 84866023056     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2012.06.004     Document Type: Article

References (25)

1. Balgobind B.V., Raimondi S.C., Harbott J., Zimmermann M., Alonzo T.A., Auvrignon A., Beverloo H.B., Chang M., Creutzig U., Dworzak M.N., Forestier E., Gibson B., Hasle H., Harrison C.J., Heerema N.A., Kaspers G.J., Leszl A., Litvinko N., Nigro L.L., Morimoto A., Perot C., Pieters R., Reinhardt D., Rubnitz J.E., Smith F.O., Stary J., Stasevich I., Strehl S., Taga T., Tomizawa D., Webb D., Zemanova Z., Zwaan C.M., van den Heuvel-Eibrink M.M. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood 2009, 114:2489-2496.
2. Biondi A., Cimino G., Pieters R., Pui C.H. Biological and therapeutic aspects of infant leukemia. Blood 2000, 96:24-33.
3. Bizarro S., Cerveira N., Correia C., Lisboa S., Peixoto A., Norton L., Teixeira M.R. Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia. Cancer Genet. Cytogenet. 2007, 178:61-64.
4. Cerveira N., Bizarro S., Teixeira M.R. MLL-SEPTIN gene fusions in hematological malignancies. Biol. Chem. 2011, 392:713-724.
5. Cerveira N., Correia C., Bizarro S., Pinto C., Lisboa S., Mariz J.M., Marques M., Teixeira M.R. SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23). Oncogene 2006, 25:6147-6152.
6. Cerveira N., Meyer C., Santos J., Torres L., Lisboa S., Pinheiro M., Bizarro S., Correia C., Norton L., Marschalek R., Teixeira M.R. A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia. BMC Cancer 2010, 10:518.
7. Cerveira N., Micci F., Santos J., Pinheiro M., Correia C., Lisboa S., Bizarro S., Norton L., Glomstein A., Asberg A.E., Heim S., Teixeira M.R. Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: identification of novel fusion transcripts and cloning of genomic breakpoint junctions. Haematologica 2008, 93:1076-1080.
8. Coenen E.A., Zwaan C.M., Meyer C., Marschalek R., Pieters R., van der Veken L.T., Beverloo H.B., van den Heuvel-Eibrink M.M. KIAA1524: a novel MLL translocation partner in acute myeloid leukemia. Leuk. Res. 2011, 35:133-135.
9. Daser A., Rabbitts T.H. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin. Cancer Biol. 2005, 15:175-188.
10. De Braekeleer E., Meyer C., Douet-Guilbert N., Basinko A., Le Bris M.J., Morel F., Berthou C., Marschalek R., Férec C., De Braekeleer M. Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory. Mol. Oncol. 2011, 5:555-563.
11. Gisselsson D. Cytogenetic methods. Cancer Cytogenetics 2009, 9-16. John Wiley & Sons Inc., New Jersey. S. Heim, F. Mitelman (Eds.).
12. Harrison C.J., Haas O., Harbott J., Biondi A., Stanulla M., Trka J., Izraeli S. Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfürt-Münster study group. Br. J. Haematol. 2010, 151:132-142.
13. Hayette S., Tigaud I., Maguer-Satta V., Bartholin L., Thomas X., Charrin C., Gadoux M., Magaud J.P., Rimokh R. Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia. Blood 2002, 99:4647-4649.
14. Meyer C., Schneider B., Reichel M., Angermueller S., Strehl S., Schnittger S., Schoch C., Jansen M.W., van Dongen J.J., Pieters R., Haas O.A., Dingermann T., Klingebiel T., Marschalek R. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:449-454.
15. Meyer C., Schneider B., Jakob S., Strehl S., Attarbaschi A., Schnittger S., Schoch C., Jansen M.W., van Dongen J.J., den Boer M.L., Pieters R., Ennas M.G., Angelucci E., Koehl U., Greil J., Griesinger F., Zur Stadt U., Eckert C., Szczepański T., Niggli F.K., Schäfer B.W., Kempski H., Brady H.J., Zuna J., Trka J., Nigro L.L., Biondi A., Delabesse E., Macintyre E., Stanulla M., Schrappe M., Haas O.A., Burmeister T., Dingermann T., Klingebiel T., Marschalek R. The MLL recombinome of acute leukemias. Leukemia 2006, 20:777-784.
16. Meyer C., Kowarz E., Hofmann J., Renneville A., Zuna J., Trka J., Ben Abdelali R., Macintyre E., De Braekeleer E., De Braekeleer M., Delabesse E., de Oliveira M.P., Cavé H., Clappier E., van Dongen J.J., Balgobind B.V., van den Heuvel-Eibrink M.M., Beverloo H.B., Panzer-Grümayer R., Teigler-Schlegel A., Harbott J., Kjeldsen E., Schnittger S., Koehl U., Gruhn B., Heidenreich O., Chan L.C., Yip S.F., Krzywinski M., Eckert C., Möricke A., Schrappe M., Alonso C.N., Schäfer B.W., Krauter J., Lee D.A., Zur Stadt U., Te Kronnie G., Sutton R., Izraeli S., Trakhtenbrot L., Lo Nigro L., Tsaur G., Fechina L., Szczepanski T., Strehl S., Ilencikova D., Molkentin M., Burmeister T., Dingermann T., Klingebiel T., Marschalek R. New insights to the MLL recombinome of acute leukemias. Leukemia 2009, 23:1490-1499.
17. Mrózek K., Heinonen K., Lawrence D., Carroll A.J., Koduru P.R., Rao K.W., Strout M.P., Hutchison R.E., Moore J.O., Mayer R.J., Schiffer C.A., Bloomfield C.D. Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Blood 1997, 90:4532-4538.
18. Muntean A.G., Hess J.L. The pathogenesis of mixed-lineage leukemia. Annu. Rev. Pathol. Mech. Dis. 2012, 7:283-301.
19. Pui C.H., Campana D. Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia. Leukemia 2007, 4:593-594.
20. Rubnitz J.E., Raimondi S.C., Tong X., Srivastava D.K., Razzouk B.I., Shurtleff S.A., Downing J.R., Pui C.H., Ribeiro R.C., Behm F.G. Favorable impact of the t(9;11) in childhood acute myeloid leukemia. J. Clin. Oncol. 2002, 20:2302-2309.
21. Santos J., Cerveira N., Correia C., Lisboa S., Pinheiro M., Torres L., Bizarro S., Vieira J., Viterbo L., Mariz J.M., Teixeira M.R. Coexistence of alternative MLL-SEPT9 fusion transcripts in an acute myeloid leukemia with t(11;17)(q23;q25). Cancer Genet. Cytogenet. 2010, 197:60-64.
22. Schoch C., Schnittger S., Klaus M., Kern W., Hiddemann W., Haferlach T. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 2003, 102:2395-2402.
23. Shaffer L.G., Slovak M.L., Campbell L.J. An International System for Human Cytogenetic Nomenclature 2009, Karger Publishers, Basel.
24. Tamai H., Inokuchi K. 11q23/MLL acute leukemia: update of clinical aspects. J. Clin. Exp. Hematopathol. 2010, 50:91-98.
25. von Neuhoff C., Reinhardt D., Sander A., Zimmermann M., Bradtke J., Betts D.R., Zemanova Z., Stary J., Bourquin J.P., Haas O.A., Dworzak M.N., Creutzig U. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. J. Clin. Oncol. 2010, 28:2682-2689.